A protest over a draft decision not to recommend a new cystic fibrosis drug is due later. Campaigners keen to see Kalydeco introduced across Wales are aiming to make their voices heard outside a meeting of the All Wales Medicines Strategy Group at the Angel Hotel in Abergavenny.
The group will look at the recommendation and decide whether to approve it or not. The drug - which is already available in England, Scotland and Northern Ireland - is the first licensed drug that treats the G551D mutation - the fundamental defect in those with cystic fibrosis.
More top news
The Dog's Trust in Bridgend says it is looking to re-home six Staffordshire Bull Terriers.
Drinking red wine may elicit conflicting responses of feeling both sexy and tired, a new study suggests.
Politicians, businesses and campaigners will keep a close eye on Philip Hammond's second budget to see how it affects Wales